Price Chart

Profile

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases.  It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
URL https://www.atarabio.com
Investor Relations URL https://investors.atarabio.com/
HQ State/Province California
Sector Health Care
Industry Biotechnology
Equity Style Small Cap/Growth
Next Earnings Release Mar. 28, 2025 (est.)
Last Earnings Release Nov. 12, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases.  It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
URL https://www.atarabio.com
Investor Relations URL https://investors.atarabio.com/
HQ State/Province California
Sector Health Care
Industry Biotechnology
Equity Style Small Cap/Growth
Next Earnings Release Mar. 28, 2025 (est.)
Last Earnings Release Nov. 12, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A